[
  {
    "ts": null,
    "headline": "How Unusual Options Standout Boston Scientific (BSX) is Signaling a Statistical Edge",
    "summary": "BSX stock may extend its solid performance as options activity and historical patterns suggest a bullish setup with favorable short-term odds.",
    "url": "https://finnhub.io/api/news?id=f821d7ad65233361d5063be6da7068b9c2995414a9a8690e7ae9f60cadf93f39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751909402,
      "headline": "How Unusual Options Standout Boston Scientific (BSX) is Signaling a Statistical Edge",
      "id": 135806232,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BSX stock may extend its solid performance as options activity and historical patterns suggest a bullish setup with favorable short-term odds.",
      "url": "https://finnhub.io/api/news?id=f821d7ad65233361d5063be6da7068b9c2995414a9a8690e7ae9f60cadf93f39"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (NYSE:BSX) Expands FARAPULSE System FDA Approval For Persistent Atrial Fibrillation",
    "summary": "Boston Scientific (NYSE:BSX) recently achieved FDA approval to expand the FARAPULSE™ Pulsed Field Ablation (PFA) System's use, enhancing treatment options for persistent atrial fibrillation. This significant development aligns with the 15% share price increase over the last quarter. The company's inclusion in key Russell indices and positive clinical trial results may have amplified its stock performance. While the broader market experienced growth, Boston Scientific's strategic advancements...",
    "url": "https://finnhub.io/api/news?id=d39c9657b9a5200bc241a3c457379a2e1f74ff6773c701850cfdd7d4cc0b3276",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751908751,
      "headline": "Boston Scientific (NYSE:BSX) Expands FARAPULSE System FDA Approval For Persistent Atrial Fibrillation",
      "id": 135789109,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (NYSE:BSX) recently achieved FDA approval to expand the FARAPULSE™ Pulsed Field Ablation (PFA) System's use, enhancing treatment options for persistent atrial fibrillation. This significant development aligns with the 15% share price increase over the last quarter. The company's inclusion in key Russell indices and positive clinical trial results may have amplified its stock performance. While the broader market experienced growth, Boston Scientific's strategic advancements...",
      "url": "https://finnhub.io/api/news?id=d39c9657b9a5200bc241a3c457379a2e1f74ff6773c701850cfdd7d4cc0b3276"
    }
  },
  {
    "ts": null,
    "headline": "Will J&J's Q2 Results Reflect End of MedTech Issues & Higher Sales?",
    "summary": "JNJ's MedTech unit eyes second-half growth despite China headwinds, U.S. competition and tariff pressure.",
    "url": "https://finnhub.io/api/news?id=4bca62ca10dbb2cc03e3bef77803098dfb8fb1e550a65d018b7edfe6bd31e2c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751895000,
      "headline": "Will J&J's Q2 Results Reflect End of MedTech Issues & Higher Sales?",
      "id": 135787470,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "JNJ's MedTech unit eyes second-half growth despite China headwinds, U.S. competition and tariff pressure.",
      "url": "https://finnhub.io/api/news?id=4bca62ca10dbb2cc03e3bef77803098dfb8fb1e550a65d018b7edfe6bd31e2c6"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System",
    "summary": "Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) labeling for the FARAPULSE™ Pulsed Field Ablation (PFA) System. The updated labeling now includes approval for the system in the treatment of drug refractory, symptomatic persistent atrial fibrillation (AF), an arrythmia in which the heart beats abnormally for at least seven days.",
    "url": "https://finnhub.io/api/news?id=14cebf87c88dc394471e046a5f2c2c831873955bee5ca743f5d9d3da964ff216",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751886000,
      "headline": "Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System",
      "id": 135789112,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the instructions for use (IFU) labeling for the FARAPULSE™ Pulsed Field Ablation (PFA) System. The updated labeling now includes approval for the system in the treatment of drug refractory, symptomatic persistent atrial fibrillation (AF), an arrythmia in which the heart beats abnormally for at least seven days.",
      "url": "https://finnhub.io/api/news?id=14cebf87c88dc394471e046a5f2c2c831873955bee5ca743f5d9d3da964ff216"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation Receives U.S. Food and Drug Administration Approval to Expand the Instructions for Use Labeling for the Farapulse Pulsed Field Ablation System",
    "summary": "Boston Scientific Corporation has received U.S. Food and Drug Administration approval to expand the instructions for use labeling for the FARAPULSE?? Pulsed Field Ablation System. The updated...",
    "url": "https://finnhub.io/api/news?id=4e1c35a372922e0b8fd7f852b97a585f92a992539b0ffe532d86c57a6f609548",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751874621,
      "headline": "Boston Scientific Corporation Receives U.S. Food and Drug Administration Approval to Expand the Instructions for Use Labeling for the Farapulse Pulsed Field Ablation System",
      "id": 135784900,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Boston Scientific Corporation has received U.S. Food and Drug Administration approval to expand the instructions for use labeling for the FARAPULSE?? Pulsed Field Ablation System. The updated...",
      "url": "https://finnhub.io/api/news?id=4e1c35a372922e0b8fd7f852b97a585f92a992539b0ffe532d86c57a6f609548"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific receives FDA approval for expanded labeling of Farapulse pulsed field ablation system",
    "summary": "Boston Scientific Corp:Boston Scientific receives FDA approval for expanded labeling of Farapulse™ pulsed field ablation systemBoston Scientific Corp: anticipates CE mark & approval in Japan and...",
    "url": "https://finnhub.io/api/news?id=bceb00f88df5ce92694ecd04c0454e0eefe2fa910cd3d42d283ae50315d09e41",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751872224,
      "headline": "Boston Scientific receives FDA approval for expanded labeling of Farapulse pulsed field ablation system",
      "id": 135784669,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Boston Scientific Corp:Boston Scientific receives FDA approval for expanded labeling of Farapulse™ pulsed field ablation systemBoston Scientific Corp: anticipates CE mark & approval in Japan and...",
      "url": "https://finnhub.io/api/news?id=bceb00f88df5ce92694ecd04c0454e0eefe2fa910cd3d42d283ae50315d09e41"
    }
  }
]